Caffeine use by children: The quest for enhancement

Substance Use and Misuse

Volumn 42, Issue 8, 2007, Pages 1237-1251

  Bramstedt, Katrina A ^a,b  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b Clinical Ethicist Program in Medicine and Human Values   (United States)

Author keywords

Biomedical enhancement; Caffeine; Children; Cognition; Ethics; Performance enhancement; Potentiation; Recreational drug use

Indexed keywords

2,4 DINITROPHENOL; 3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; ACETYLSALICYLIC ACID; ALCOHOL; CAFFEINE; DEXAMPHETAMINE; DIURETIC AGENT; EPHEDRINE; GROWTH HORMONE; METHYLPHENIDATE; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PHENOBARBITAL; PHENYTOIN; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ACADEMIC ACHIEVEMENT; ADDICTION; ATHLETE; ATTENTION DEFICIT DISORDER; ATTITUDE; BEVERAGE; CHILD; CHILD BEHAVIOR; COGNITION; DRUG ABUSE; EATING DISORDER; ENERGY; HUMAN; INTOXICATION; MEDICAL ETHICS; MENTAL PERFORMANCE; MYOCLONUS; PRIORITY JOURNAL; REVIEW; SAFETY; SEROTONIN SYNDROME; SPORT; SUICIDE; TACHYCARDIA;

ACHIEVEMENT; ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIOMEDICAL ENHANCEMENT; CAFFEINE; CANDY; CARBONATED BEVERAGES; CARDIOTONIC AGENTS; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD PSYCHOLOGY; COGNITION; DOPING IN SPORTS; FEMALE; HUMANS; MALE; OVERDOSE; PHYSICAL ENDURANCE; PSYCHOMOTOR PERFORMANCE; SEROTONIN SYNDROME; SPORTS; STREET DRUGS;

EID: 34547665092     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.1080/10826080701208962     Document Type: Review

References (58)

1. Advocare. (2005). Product facts and ingredients: KickStart SPARK™. Retrieved October 12, 2005, from http://www.advocare.com/ store/images/labels/k2083.pdf
2. American Academy of Pediatrics. (2005). Policy statement: Use of performance enhancing substances. Pediatrics 115:1103-1106.
3. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
4. Babcock, Q., Byrne, T. (2000). Student perceptions of methylphenidate abuse at a public liberal arts college. Journal of American College Health 49:143-145.
5. Bahrke, M. S., Yesalis, C. E., Brower, K. J. (1998). Anabolic-androgenic steroid abuse and performance-enhancing drugs among adolescents. Child and Adolescent Psychiatric Clinics of North America 7:821-838.
6. Bernstein, G. A., Carroll, M. E., Thuras, P. D., Cosgrove, K. P., Roth, M. E. (2002). Caffeine dependence in teenagers. Drug and Alcohol Dependence 66:1-6.
7. Bradley, J. R., Petree, A. (1990). Caffeine consumption, expectancies of caffeine-enhanced performance, and caffeinism symptoms among university students. Journal of Drug Education 20:319-328.
8. Broderick, P., Benjamin, A. B. (2004). Caffeine and psychiatric symptoms: A review. Journal of the Oklahoma State Medical Association 97:538-542.
9. Canadian Centre for Drug-Free Sport. (1993). National School Survey on Drugs and Sport. Ottawa, Ontario, Canada.
10. Cole, K. J., Costill, D. L., Starling, R. D., Goodpaster, B. H., Trappe, S. W., Fink, W. J. (1996). Effect of caffeine ingestion on perception of effort and subsequent work production. International Journal of Sport Nutrition 6:14-23.
11. Commonwealth of Australia. (2006). Australia New Zealand Food Standards Code. Standard 2.6.4: Formulated Caffeinated Beverages.
12. Delbeke, F. T., Debackere, M. (1984). Caffeine: Use and abuse in sports. International Journal of Sports Medicine 5:179-182.
13. Forman, E. S., Dekker, A. H., Javors, J. R., Davison, D. T. (1995). High-risk behaviors in teenage male athletes. Clinical Journal of Sports Medicine 5:36-42.
14. Forman, J., Aizer, A., Young, C. R. (1997). Myocardial infarction resulting from caffeine overdose in an anorectic woman. Annals of Emergency Medicine 29:178-180.
15. Garriott, J. C., Simmons, L. M., Poklis, A., Mackell, M. A. (1985). Five cases of fatal overdose from caffeine-containing "look-alike" drugs. Journal of Analytical Toxicology 9:141-143.
16. Gilliland, K., Andress, D. (1981). Ad lib caffeine consumption, symptoms of caffeinism, and academic performance. American Journal of Psychiatry 138:512-514.
17. Holmgren, P., Nord́en-Pettersson, L., Ahlner, J. (2004). Caffeine fatalities - Four case reports. Forensic Science International 139:71-73.
18. Jafri, S. H., Cook, J. W., Reed, R. R., Beebe, D. K. (2004). Acute onset of bilateral myoclonus in a 16-year-old female. Journal of the Mississippi State Medical Association 45:169-172.
19. Kerrigan, S., Lindsey, T. (2005). Fatal caffeine overdose: Two case reports. Forensic Science International 153:67-69.
20. Klingler, W., Heffron, J. J., Jurkat-Rott, K., O'sullivan, G., Alt, A., Schlesinger, F., Bufler, J., Lehmann-Horn, F. (2005). 3,4- Methylenedioxymethamphetamine (Ecstasy) activates skeletal muscle nicotinic acetylcholine receptors. Journal of Pharmacology and Experimental Therapeutics 314:1267-1273.
21. Krahn, D. D., Hasse, S., Ray, A., Gosnell, B., Drewnowski, A. (1991). Caffeine consumption in patients with eating disorders. Hospital and Community Psychiatry 42:313-315.
22. Lambert, G. H., Schoeller, D. A., Kotake, A. N., Flores, C., Hay, D. (1986). The effect of age, gender, and sexual maturation on the caffeine breath test. Developmental Pharmacology and Therapeutics, 9, 375-388.
23. Lande, R. G. (2005). Caffeine-related psychiatric disorders. Retrieved November 11, 2005, from http://www.emedicine.com/med/topic3115.htm
24. Leon, M. R. (2000). Effects of caffeine on cognitive, psychomotor, and affective performance of children with attention-deficit/hyperactivity disorder. Journal of Attention Disorders 4:27-47.
25. Leson, C. L., McGuigan, M. A., Bryson, S. M. (1988). Caffeine overdose in an adolescent male. Journal of Toxicology and Clinical Toxicology 26:407-415.
26. Lutz, E. G. (1978). Restless legs, anxiety and caffeinism. Journal of Clinical Psychiatry 39:693-698.
27. McCabe, S. E., Teter, C. J., Boyd, C. J. (2004). The use, misuse and diversion of prescription stimulants among middle and high school students. Substance Use & Misuse 39:1095-1116.
28. McGee, M. B. (1980). Caffeine poisoning in a 19-year-old female. Journal of Forensic Science 25:29-32.
29. McNamara, R., Kerans, A., O'Neill, B., Harkin, A. (2006). Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love"). Neuropharmacology 50:69-80.
30. Mehlman, M. J. (2004). Cognition-enhancing drugs. Milbank Quarterly 82:483-506.
31. Mehlman, M. J. (2005, August). Cognition-enhancing drugs: An ethical analysis. Paper presented at the XIXth European Conference on Philosophy of Medicine and Health Care, Barcelona, Spain.
32. Miller, M. C. (2005). What are caffeine's psychological benefits and risks? Harvard Mental Health Letter 22:8.
33. Mitchell, P. J., Redman, J. R. (1992). Effects of caffeine, time of day and user history on study-related performance. Psychopharmacology (Berlin) 109:121-126.
34. Musser, C. J., Ahmann, P. A., Theye, F. W., Mundt, P., Broste, S. K., Mueller-Rizner, N. (1998). Stimulant use and the potential for abuse in Wisconsin as reported by school administrators and longitudinally followed children. Journal of Developmental and Behavioral Pediatrics 19:187-192.
35. Nagesh, R. V., Murphy, K. A., Jr. (1988). Caffeine poisoning treated by hemoperfusion. American Journal of Kidney Disease 12:316-318.
36. National Collegiate Athletic Association. (2006). NCAA banned-drug classes 2006-2007. Retrieved June 19, 2006, from http://www1.ncaa.org/ membership/ed_outreach/health-safety/drug_testing/banned_drug_classes.pdf
37. National Federation of State High School Associations. (2003, November). Sports medicine: NFHS position statement on supplements. Retrieved October 12, 2005, from www.nfhs.org
38. Oberstar, J. V., Bernstein, G. A., Thuras, P. D. (2002). Caffeine use and dependence in adolescents: One-year follow-up. Journal of Child and Adolescent Psychopharmacology 12:127-135.
39. Parrott, A. C. (2004). Is Ecstasy MDMA? A review of the proportion of Ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity. Psychopharmacology (Berlin) 173:234-241.
40. Rapoport, J. L., Elkins, R., Neims, A., Zahn, T., Berg, C. J. (1981). Behavioral and autonomic effects of caffeine in normal boys. Developmental Pharmacology and Therapeutics 3:74-82.
41. Rapoport, J. L., Jensvold, M., Elkins, R., Buchsbaum, M. S., Weingartner, H., Ludlow, C., Zahn, T. P., Berg, C. J., Neims, A. H. (1981). Behavioral and cognitive effects of caffeine in boys and adult males. Journal of Nervous and Mental Disease 169:726-732.
42. Rowland, A. S., Lesesne, C. A., Abramowitz, A. J. (2002). The epidemiology of attention-deficit/ hyperactivity disorder (ADHD): A public health view. Mental Retardation and Developmental Disabilities Research Reviews 8:162-170.
43. Schifano, F., Oyefeso, A., Webb, L., Pollard, M., Corkery, J., Ghodse, A. H. (2003). Review of deaths related to taking Ecstasy, England and Wales, 1997-2000. British Medical Journal 326:80-81.
44. Shaul, P. W., Farrell, M. K., Maloney, M. J. (1984). Caffeine toxicity as a cause of acute psychosis in anorexia nervosa. Journal of Pediatrics 105:493-495.
45. Shioda, K., Nisijima, K., Nishida, S., Kato, S. (2004). Possible serotonin syndrome arising from an interaction between caffeine and serotonergic antidepressants. Human Psychopharmacology and Clinical Experimentation 19:353-354.
46. Shum, S., Seale, C., Hathaway, D., Chucovich, V., Beard, D. (1997). Acute caffeine ingestion fatalities: Management issues. Veterinary and Human Toxicology 39:228-230.
47. Sinclair, C. J. D., Geiger, J. D. (2000). Caffeine use in sports: A pharmacologic review. Journal of Sports Medicine and Physical Fitness, 40, 71-79.
48. Smith, A. P. (2005). Caffeine at work. Human Psychopharmacology 206:441-445.
49. Sours, J. A. (1983). Case reports of anorexia nervosa and caffeinism. American Journal of Psychiatry 140:235-236.
50. Spriet, L. L. (1995). Caffeine and performance. International Journal of Sports Nutrition 5(Suppl.):S84-S99.
51. Stillner, V., Popkin, M. K., Pierce, C. M. (1978). Caffeine-induced delirium during prolonged competitive stress. American Journal of Psychiatry 135:855-856.
52. Stock, S. L., Goldberg, E., Corbett, S., Katzman, D. K. (2002). Substance use in female adolescents with eating disorders. Journal of Adolescent Health 31:176-182.
53. Supreme Court of the Northern Territory of Australia. (2001). R v. H. File number SCC 20107499.
54. Warner, M. (2005, November 23). A jolt of caffeine, by the can. New York Times, pp. C1, C15.
55. Winek, C. L., Wahba, W., Williams, K., Blenko, J., Janssen, J. (1985). Caffeine fatality: A case report. Forensic Science International 29:207-211.
56. Wrenn, K. D., Oschner, I. (1989). Rhabdomyolysis induced by a caffeine overdose. Annals of Emergency Medicine 18:94-97.
57. Wurl, P. (1994). Life-threatening caffeine poisoning by using coffee as a psychoactive drug. Wiener Klinische Wochenschrift 106:359-361.
58. Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Magder, L., Soeken, K., Boles, M., Lynch, F., Riddle M. A. (2003). Psychotropic practice patterns for youth. Archives of Pediatric and Adolescent Medicine 157:17-25.